ACSL1 Antikörper (AA 1-100)
-
- Target Alle ACSL1 (Acsl1) Antikörper anzeigen
- ACSL1 (Acsl1) (Acyl-CoA Synthetase Long-Chain Family Member 1 (Acsl1))
-
Bindungsspezifität
- AA 1-100
-
Reaktivität
- Human, Maus, Ratte, Primate
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser ACSL1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Verwendungszweck
- Rabbit polyclonal antibody raised against synthetic peptide of ACSL1.
- Kreuzreaktivität
- Human, Maus, Primate, Ratte
- Immunogen
- A synthetic peptide corresponding to amino acids 1-100 of human ACSL1.
- Top Product
- Discover our top product Acsl1 Primärantikörper
-
-
- Applikationshinweise
-
Western Blot (1 μg/mL)
The optimal working dilution should be determined by the end user. - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- In PBS (30 % glycerol, 0.09 % sodium azide)
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
-
Store at 4°C for short term. For long term storage store at -20°C.
Aliquot to avoid repeated freezing and thawing.
-
-
Fatty acid transport protein 1 and long-chain acyl coenzyme A synthetase 1 interact in adipocytes." in: Journal of lipid research, Vol. 47, Issue 3, pp. 665-72, (2006) (PubMed).
: "Overexpression of acyl-CoA synthetase-1 increases lipid deposition in hepatic (HepG2) cells and rodent liver in vivo." in: American journal of physiology. Endocrinology and metabolism, Vol. 291, Issue 4, pp. E737-44, (2006) (PubMed).
: "
-
Fatty acid transport protein 1 and long-chain acyl coenzyme A synthetase 1 interact in adipocytes." in: Journal of lipid research, Vol. 47, Issue 3, pp. 665-72, (2006) (PubMed).
-
- Target
- ACSL1 (Acsl1) (Acyl-CoA Synthetase Long-Chain Family Member 1 (Acsl1))
- Andere Bezeichnung
- ACSL1 (Acsl1 Produkte)
- Synonyme
- ACS1 antikoerper, FACL1 antikoerper, FACL2 antikoerper, LACS antikoerper, LACS1 antikoerper, LACS2 antikoerper, Acas antikoerper, Acas1 antikoerper, Acs antikoerper, FACS antikoerper, Facl2 antikoerper, ACS antikoerper, COAA antikoerper, zgc:110081 antikoerper, CER8 antikoerper, ECERIFERUM 8 antikoerper, LONG-CHAIN ACYL-COA SYNTHASE 1 antikoerper, T8I13.8 antikoerper, F13F21.14 antikoerper, F13F21_14 antikoerper, LATERAL ROOT DEVELOPMENT 2 antikoerper, LRD2 antikoerper, long-chain acyl-CoA synthetase 2 antikoerper, acyl-CoA synthetase long chain family member 1 antikoerper, acyl-CoA synthetase long-chain family member 1 antikoerper, acyl-CoA synthetase long chain family member 1a antikoerper, AMP-dependent synthetase and ligase family protein antikoerper, long-chain acyl-CoA synthetase 2 antikoerper, ACSL1 antikoerper, Acsl1 antikoerper, acsl1a antikoerper, LACS1 antikoerper, LACS2 antikoerper
- Gen-ID
- 2180
- Pathways
- Regulation of Lipid Metabolism by PPARalpha
-